BIOCOM 4th AMR Conference

24 Aug 2020 - 28 Aug 2020

The BIOCOM 4th AMR conference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market.

In view of the continuing uncertain situation and travel restrictions due to the COVID-19 pandemic, the 4th AMR Conference will take place as a digital event during the week of 24–28 August 2020.

Find out more about this year’s conference here

View full programme

Sessions with speakers from GARDP include:

Day 1: Monday August 24

13:30–15:00 CEST

Opening Session | Infectious diseases in the global spotlight: Why COVID-19 has an impact on AMR



Manica Balasegaram – Executive Director, GARDP

Christian Drosten – Director of Institute of Virology, Charité (tbc)

Jordi Vila – Head of Service, Biomedical Diagnostic Center, Microbiology, Hospital Clinic Barcelona (tbc)


Day 2: Tuesday August 25

13:30–15:00 CEST

Business models | The AMR company of the future – Which route to success



Marc Gitzinger – CEO, BioVersys AG

Cherif Bousselham – Head of EMEA (Europe, Middle East and Africa), Accelerate Diagnostics Inc.

Jean-Pierre Paccaud – Director of Business Development and Corporate Strategy, GARDP

Ken Bradley – Global Head, Infectious Disease Discovery, Roche


Day 3: Wednesday August 26

15:15–17:00 CEST

Clinical trials | Why global networks are crucial to speed up late stage clinical development



Seamus O’Brien, R&D Director, GARDP

Tim Jinks, Head of Antibiotic Resistance Infections Program, Wellcome Trust

Florence Séjourne, CEO, DaVolterra

Kamini Walia, Head of AMR, ICMR, Government of India


We use cookies to provide you a better experience and understand how our site is being used. To consent to the use of cookies, click ‘Accept’. Learn more about our cookie and privacy policy.